Indo Us Bio-Tech Limited (BOM:541304)
India · Delayed Price · Currency is INR 93.15
+2.90 (3.21%)
At close: Jun 22, 2026
Indo Us Bio-Tech Revenue
In the fiscal year ending March 31, 2026, Indo Us Bio-Tech had annual revenue of 1.10B INR with 6.36% growth. Indo Us Bio-Tech had revenue of 260.25M in the quarter ending March 31, 2026, a decrease of -22.05%.
Revenue
1.10B
Revenue Growth
+6.36%
P/S Ratio
1.62
Revenue / Employee
n/a
Employees
883
Market Cap
1.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.10B | 66.01M | 6.36% |
| Mar 31, 2025 | 1.04B | 310.02M | 42.56% |
| Mar 31, 2024 | 728.36M | 110.92M | 17.96% |
| Mar 31, 2023 | 617.45M | 116.86M | 23.34% |
| Mar 31, 2022 | 500.59M | 99.48M | 24.80% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Amir Chand Jagdish Kumar (Exports) | 22.87B |
| JK Agri Genetics | 1.58B |
| Mangalam Seeds | 1.12B |
| Sheel Biotech | 1.11B |
| Tierra Agrotech | 984.67M |
| Stanbik Agro | 858.95M |
| Saptarishi Agro Industries | 812.03M |
| Unisem Agritech | 810.34M |
Indo Us Bio-Tech News
- 1 year ago - Indo US Bio-Tech share price surges 3% after signing MoU for Pratap Hybrid Maize -6 - Business Upturn